Kanô H, Silva E C
Z Urol Nephrol. 1978 Mar;71(3):175-9.
The loss of blood during adenectomies was quantitatively measured in 25 prostatic patients with or without Raveron-premediaction. The result in the 11 patients pretreated with Raveron was in comparison to the 14 untreated patients a reduction to one half of the blood lost by gram of the tumour tissue removed. Furthermore we observed a better demarcation of the tumour-tissue and operability together with a postoperative recovery without complications in patients treated with Raveron.
在25例前列腺患者中，对有或没有接受拉韦龙预处理的患者在腺切除术中的失血量进行了定量测量。与14例未接受治疗的患者相比，11例接受拉韦龙预处理的患者每克切除肿瘤组织的失血量减少了一半。此外，我们观察到，接受拉韦龙治疗的患者肿瘤组织的界限更清晰，可操作性更强，术后恢复也无并发症。
